Phase II study of CHIP chemotherapy in a
โ
Alec S. Goldenberg; David Kelsen; James Dougherty; Gordon Magill
๐
Article
๐
1990
๐
Springer US
๐
English
โ 412 KB
Iproplatin (CHIP) is a second generation cisplatin analogue which has completed its Phase I trials. We studied the efficacy and toxicity of CHIP in 36 previously untreated patients with advanced upper gastrointestinal tract adenocarcinomas (GE junction, cardia, antrum and body of the stomach). The s